Articles producció científica> Ciències Mèdiques Bàsiques

Update and recent advances on azole resistance mechanisms in Aspergillus

  • Identification data

    Identifier: imarina:5873560
    Authors:
    Perez-Cantero, AlbaLopez-Fernandez, LoidaGuarro, JosepCapilla, Javier
    Abstract:
    Aspergillus fumigatus is the main causal agent of invasive aspergillosis (IA) although other species of the genus can also be the cause of IA, such as A. flavus, A. terreus, A. niger and related cryptic species. This infectious disease mainly affects immunosuppressed patients and it is linked to elevated mortality rates. Being voriconazole (VRC) the treatment of choice for this condition, the relevant increase in the number of azole resistant isolates in recent years has gathered alarming attention, as it translates into a clinical failure increment as well. In this review, we summarize and discuss the azole resistance molecular data described to date in the most clinically prevalent sections of Aspergillus, comprising mechanisms that involve target proteins Cyp51 and ATP Binding Cassette (ABC) or Major Facilitator Superfamily (MFS) efflux pumps. Other resistance mechanisms proposed but not fully-characterized yet are also discussed.Copyright © 2019. Published by Elsevier B.V.
  • Others:

    Author, as appears in the article.: Perez-Cantero, Alba; Lopez-Fernandez, Loida; Guarro, Josep; Capilla, Javier
    Department: Ciències Mèdiques Bàsiques
    URV's Author/s: Capilla Luque, Javier / Guarro Artigas, Josep / LÓPEZ FERNÁNDEZ, LOIDA / PÉREZ CANTERO, ALBA
    Keywords: Voriconazole resistance Voriconazole Triazoles Triazole resistance Major facilitator superfamily Itraconazole resistance In-vitro Humans Fungal proteins Fumigatus Eucast technical note Efflux pumps Drug resistance, fungal Cytochrome p450 family 51 Cyp51 Cross-resistance Azoles Atp-binding cassette transporters Aspergillus fumigatus Aspergillus Aspergillosis Antifungal resistance Antifungal drug-resistance Antifungal agents 14-alpha-sterol demethylase cyp51a
    Abstract: Aspergillus fumigatus is the main causal agent of invasive aspergillosis (IA) although other species of the genus can also be the cause of IA, such as A. flavus, A. terreus, A. niger and related cryptic species. This infectious disease mainly affects immunosuppressed patients and it is linked to elevated mortality rates. Being voriconazole (VRC) the treatment of choice for this condition, the relevant increase in the number of azole resistant isolates in recent years has gathered alarming attention, as it translates into a clinical failure increment as well. In this review, we summarize and discuss the azole resistance molecular data described to date in the most clinically prevalent sections of Aspergillus, comprising mechanisms that involve target proteins Cyp51 and ATP Binding Cassette (ABC) or Major Facilitator Superfamily (MFS) efflux pumps. Other resistance mechanisms proposed but not fully-characterized yet are also discussed.Copyright © 2019. Published by Elsevier B.V.
    Thematic Areas: Saúde coletiva Química Pharmacology (medical) Pharmacology & pharmacy Odontología Nutrição Microbiology (medical) Microbiology Medicine (miscellaneous) Medicina veterinaria Medicina iii Medicina ii Medicina i Materiais Interdisciplinar Infectious diseases General medicine Farmacia Engenharias iii Engenharias ii Enfermagem Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências ambientais Ciências agrárias i Biotecnología Biodiversidade
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 09248579
    Author's mail: javier.capilla@urv.cat
    Author identifier: 0000-0002-0765-6403
    Record's date: 2025-01-08
    Paper version: info:eu-repo/semantics/acceptedVersion
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Paper original source: International Journal Of Antimicrobial Agents. 55 (1): 105807-
    APA: Perez-Cantero, Alba; Lopez-Fernandez, Loida; Guarro, Josep; Capilla, Javier (2020). Update and recent advances on azole resistance mechanisms in Aspergillus. International Journal Of Antimicrobial Agents, 55(1), 105807-. DOI: 10.1016/j.ijantimicag.2019.09.011
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2020
    Publication Type: Journal Publications
  • Keywords:

    Infectious Diseases,Medicine (Miscellaneous),Microbiology,Microbiology (Medical),Pharmacology & Pharmacy,Pharmacology (Medical)
    Voriconazole resistance
    Voriconazole
    Triazoles
    Triazole resistance
    Major facilitator superfamily
    Itraconazole resistance
    In-vitro
    Humans
    Fungal proteins
    Fumigatus
    Eucast technical note
    Efflux pumps
    Drug resistance, fungal
    Cytochrome p450 family 51
    Cyp51
    Cross-resistance
    Azoles
    Atp-binding cassette transporters
    Aspergillus fumigatus
    Aspergillus
    Aspergillosis
    Antifungal resistance
    Antifungal drug-resistance
    Antifungal agents
    14-alpha-sterol demethylase cyp51a
    Saúde coletiva
    Química
    Pharmacology (medical)
    Pharmacology & pharmacy
    Odontología
    Nutrição
    Microbiology (medical)
    Microbiology
    Medicine (miscellaneous)
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Materiais
    Interdisciplinar
    Infectious diseases
    General medicine
    Farmacia
    Engenharias iii
    Engenharias ii
    Enfermagem
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciências ambientais
    Ciências agrárias i
    Biotecnología
    Biodiversidade
  • Documents:

  • Cerca a google

    Search to google scholar